Strategic Partnership Target Ascendia as a high-margin CDMO partner for complex formulation development, sterile and non-sterile manufacturing, and analytical services to expand their clinical trial material supply capabilities and niche commercial manufacturing.

Clinical Pipeline Enablement Position complementary pre-formulation, formulation development, and proprietary nanotechnology offerings to support Ascendia’s work with preclinical and clinical-stage drug candidates, unlocking faster go/no-go decisions and scalable manufacturing.

Expansion Opportunities Leverage Ascendia’s ongoing participation in industry events and collaborations to propose joint webinars, pilot programs, or sponsored studies that showcase innovative manufacturing solutions and accelerate technology adoption.

Global Competitiveness Highlight capabilities that differentiate Ascendia from larger CROs/CMOs, such as specialized analytical QC/micro testing, niche product manufacturing, and rapid scalability, aligning with growth targets in biotech and pharma markets.

Digital Engagement Offer data-driven collaboration tools, integrated quality systems, and digital supply chain transparency leveraging their tech stack to improve project tracking, compliance, and time-to-market for complex formulations.